Pfizer

Study brokers Interspond, Elias Research head to court over alleged trade secret violations

Monday, July 11, 2011 08:02 AM

Two trial management firms (TMOs), known more commonly in the industry as study brokers, have taken their disagreement to court.

More... »

Lilly pitches plan to overcome key patent losses

Friday, July 8, 2011 10:15 AM

Eli Lilly, only months away from losing patent protection for its top-selling drug, told investors the keys to overcoming this and other patent losses lie in its labs and emerging markets including China, according to Mercury News.

More... »

Pfizer seeking alternatives for Animal Health and Nutrition businesses

Friday, July 8, 2011 10:04 AM

Pfizer is exploring strategic alternatives for its Animal Health and Nutrition businesses based on its recent business portfolio review to determine the optimal mix of businesses for maximizing shareholder value.

More... »

Former Pfizer research chief wary of R&D strategy

Thursday, July 7, 2011 10:02 AM

Pfizer may have won over shareholders with its recent decision to pare back R&D spending, but it could be shortchanging them in the long run, Pfizer’s former research chief told Reuters.

More... »

Pfizer collaborates on drugs for Russian market

Friday, July 1, 2011 10:08 AM

Pfizer will work with a Russian venture capital company to research and market new drugs in Russia and surrounding countries, according to the Associated Press.

More... »

Pfizer’s ‘virtual’ clinical trial could have far-reaching implications for future research productivity

Monday, June 20, 2011 08:00 AM

As Pfizer begins enrolling the first-ever FDA-approved “virtual” clinical trial, which allows patients to participate from home using smartphones and computers instead of visiting a clinic, industry executives believe the study has far-reaching implications for improving the productivity of clinical trials in the future.

More... »

Pfizer puts Sandwich R&D site on market

Tuesday, June 14, 2011 02:28 PM

Pfizer's giant research base at Sandwich, southern England, has been officially put on the market by CB Richard Ellis, according to Reuters. U.S.-based Pfizer in February decided to close the site.

More... »

Strategic partnerships: a good deal for CROs, or just a cost-cutting measure by big pharma?

Monday, June 13, 2011 08:01 AM

Strategic partnerships with the top 20 pharma companies are what most sizable CROs dream of these days.

More... »

Boston's Top AMCs Join Pfizer's Centers For Therapeutic Innovation

Thursday, June 9, 2011 12:42 PM

Pfizer’s network of translational research partnerships, called the Centers for Therapeutic Innovation, has launched in Boston with Beth Israel Deaconess Medical Center, Boston University School of Medicine, Children's Hospital Boston, Harvard University, Partners HealthCare, Tufts Medical Center, Tufts University and the University of Massachusetts Medical School in Worcester.

More... »

Pfizer chooses Icon and Parexel as its two strategic outsourcing partners in 5-year deals

Monday, June 6, 2011 10:23 AM

Strategic partnerships with large pharma recently have become the holy grail among CROs. And two have been awarded by Pfizer, the largest drug maker in the world.

More... »